Trial Profile
Randomized, Open-Label, Multi-Center and Phase 3 Clinical Trial to Compare the Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury or Defect
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs SMUP-IA-01 (Primary)
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- 22 Nov 2012 New trial record